a Department of Respiratory Medicine, Glenfield Hospital, Leicester LE3 9QP, UK, b Department of Sports Science, Loughborough University of Technology, UK Dr S M Revill. BACKGROUND The purpose of this ...
Antileukotriene drugs are new therapeutic agents that have recently been approved for the treatment of asthma. Several cases of eosinophilic conditions including Churg-Strauss syndrome have been ...
1 The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong SAR Correspondence to William B Goggins III, The Jockey Club School of Public Health ...
Background Chronic obstructive pulmonary disease (COPD) is a leading cause of global mortality, yet existing risk prediction models remain limited. This study aimed to develop and validate a ...
Background Oscillatory positive expiratory pressure (OPEP) devices are intended to facilitate sputum clearance and reduce cough, but there is limited evidence for their effectiveness in COPD, or to ...
1 Department of Respiratory Medicine, Alfred Hospital and Monash University Medical School, Melbourne 3181, Australia 2 Department of Epidemiology and Preventive Medicine, Alfred Hospital and Monash ...
3 The University of Manchester, Manchester Academic Health Science Centre, University Hospital South Manchester NHS Foundation Trust, Manchester, UK 4 University Hospital of South Manchester, ...
2 Great Ormond St Hospital for Children NHS Trust, London, UK Correspondence to Mandy Bryon, Great Ormond St Hospital for Children NHS Trust, London WC1N 3JH, UK; Mandy.bryon{at}gosh.nhs.uk The ...
Pediatric Pulmonary Section, Department of Pediatrics, Baylor College of Medicine, Texas Children’s Hospital, Houston, Texas, USA Background: Mutations in the ABCA3 gene can result in fatal surfactant ...
Background Previous studies have shown that the incidence of idiopathic pulmonary fibrosis (IPF) is rising in the UK and USA. Death registrations and primary care data were used to determine the ...
Introduction Current bronchiectasis guidelines advise against the use of inhaled corticosteroids (ICS) except in patients with associated asthma, allergic bronchopulmonary aspergillosis (ABPA) and/or ...
Correspondence to Professor Claire L Shovlin, Professor of Practice (Clinical and Molecular Medicine), NHLI Vascular Science, Imperial College London, Imperial Centre for Translational and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback